Global CT/NG Testing Market Size is valued at USD 1.8 Bn in 2024 and is predicted to reach USD 4.2 Bn by the year 2034 at a 8.4% CAGR during the forecast period for 2025-2034.
Players in the CT/NG testing market have numerous prospects for expansion in developing nations, including South Korea, Mexico, Brazil, India, and South Korea. This can be ascribed to a lack of legislative restrictions, advancements in healthcare infrastructure, an increase in the number of patients, an increase in the prevalence of infections, and rising healthcare costs.
Furthermore, compared to wealthy nations, some of these countries have regulatory frameworks that are more flexible and business friendly. For instance, the OECD projects that the expanding middle-class population's purchasing power will rise from 23% in 2009 to 65% in 2022. This is anticipated to increase the middle-class population's medical needs, which would help the industry grow.
Additionally, as US and European markets develop, the majority of players will turn their attention to emerging countries. Upgrading laboratory infrastructure in emerging economies is made possible in large part by the significant investments made in healthcare and life science research in these nations. This thus encourages the construction of diagnostic equipment in laboratories and promotes the expanding use of CT/NG testing.
The CT/NG Testing market is segmented based on product, test type, technology, and end-user. The market is segmented as assays & kits and instruments/analyzers based on product. The test-type segment includes laboratory and point-of-care testing. The technology segment includes INAAT, PCR, and Immunodiagnostics. Based on end-user the market is bifurcated as diagnostic labs, hospitals & clinics.
The market for CTING testing was dominated by the assays & kits sector. Due to the strong demand and ongoing need for diagnosis and treatment, this segment has a large market share. It is a high-cost product as a result of frequent purchases, which contributes to the segment's growth.
According to test type, the lab tests segment held the majority of the CTING testing market. This market's expansion can be due to elements like the rising demand for automation in lab settings and the prevalence of numerous infectious diseases. In comparison to PoC tests, lab tests are more sensitive and specific. A controlled lab setting ensures more precise and sensitive measurements, lowering the possibility of false-negative or false-positive results. The capacity of lab testing to process more samples at once is an additional benefit. These elements should encourage the expansion of this market.
Technological developments in the area of diagnostics have largely been led by North America. The region has a solid research & development infrastructure, which has sped up the adoption of cutting-edge diagnostic platforms and methods. In addition, North America is home to several significant businesses engaged in the CT/NG testing industry. Due to the substantial knowledge, resources, and established distribution networks of these businesses, the area dominates the market. Hologic, Inc. (US), PerkinElmer, Inc. (US), Abbott Laboratories (US), and Thermo Fisher Scientific Inc. (US) are a few examples of well-known CT/NG testing businesses in North America.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 1.8 Bn |
| Revenue Forecast In 2034 | USD 4.2 Bn |
| Growth Rate CAGR | CAGR of 8.4% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Bn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, Technology, Test Type, End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Siemens Healthineers AG (Germany), Danaher (US), Becton, Dickinson and Company (US). |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
CT/NG Testing Market By Product-
CT/NG Testing Market By Test Type-
CT/NG Testing Market By Technology-
CT/NG Testing Market By End-User-
CT/NG Testing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global CT/NG Testing Market Snapshot
Chapter 4. Global CT/NG Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Assays & Kits
5.2.2. Instruments/Analyzers
Chapter 6. Market Segmentation 2: By Testing Type Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Testing Type:
6.2.1. Lab Tests
6.2.2. PoC Tests
Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Product & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
7.2.1. Isothermal Nucleic Acid Amplification Technology
7.2.2. Polymerase Chain Reaction
7.2.3. Immunodiagnostics
7.2.4. Other Technologies
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Diagnostic Laboratories
8.2.2. Hospitals & Clinics
8.2.3. Other End Users
Chapter 9. CT/NG Testing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.2. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.1.3. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.1.4. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.2.2. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.2.3. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.2.4. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User ,2021-2034
9.2.5. Europe CT/NG Testing Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.3.2. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.3.3. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.3.4. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.3.5. Asia Pacific CT/NG Testing Market revenue (US$ Million) By country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.4.2. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.4.3. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.4.4. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America CT/NG Testing Market revenue (US$ Million) By country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa CT/NG Testing Market revenue (US$ Million) By Product, (US$ Million)
9.5.2. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.5.3. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.5.4. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa CT/NG Testing Market revenue (US$ Million) By country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
10.2.2. Hologic, Inc. (US)
10.2.3. Thermo Fisher Scientific Inc. (US)
10.2.4. Abbott Laboratories (US)
10.2.5. Bio-Rad Laboratories, Inc. (US)
10.2.6. Siemens Healthineers AG (Germany)
10.2.7. Danaher (US)
10.2.8. Becton, Dickinson and Company (US).